PRINTABLE VERSIONPRINTABLE VERSION EMAILEMAIL
Frost & Sullivan Recognizes Oragenics for its Unique Probiotic that Promotes Oral Health for Both Humans and Companion Animals

Oragenics' product inimitably promotes fresh breath, oral hygiene and tooth whitening naturally

MOUNTAIN VIEW, Calif. - October 4, 2011 - Based on its recent analysis of the oral care probiotics market, Frost & Sullivan recognizes Oragenics, Inc. with the 2011 North America Frost & Sullivan Award for Product Differentiation Excellence for its Probiora 3 ®, a unique blend of probiotic organisms that are specific to the oral cavity. The patented blend of probiotics in Probiora3 ® makes the product the only one in the market to naturally aid fresh breath, oral hygiene and tooth whitening. These claims, along with Oragenics' strict quality assurance program for its contract manufacturers, innovative marketing approach, and pipeline of improvements for Probiora3 ®, makes it a worthy recipient of this award.

Probiora® is backed by years of scientific research about organisms that resolve the three oral health issues of bad breath, challenges to tooth and gum health, and tooth discoloration. The undirected discovery and comparison process is proof that the unique blend of the three organisms in Probiora3 ® is well suited for promoting oral and dental health naturally. In addition, Probiora3 ® has obtained a self-affirmed Generally Recognized as Safe (GRAS) status.

"The manufacturing process for Probiora3 ® is entrusted to partners that are good manufacturing practice-compliant and undergo a strict audit process by Oragenics," says Frost & Sullivan Senior Research Analyst Dr.Kaushik Shankar. "The company has in-house capabilities for testing the probiotic blend for viability, release kinetics, and long-term storage capabilities."

As each organism in the Probiora3 ® blend has a specific role in the final functionality of the product, custom blends can be created for specific target populations such as adults, children and companion animals. Innovations at Oragenics are expected to lead to additional delivery systems within the next nine to twelve months.

Probiora3 ® owes its success to the 'health and wellness' trend as well as the rising popularity of companion animal care, which is fuelled by the baby-boomer, empty-nester and youth populations. Probiora3 ® can be used in a gamut of food, beverage and dietary supplement products that are employed as delivery systems for probiotics. These delivery systems include dairy products, capsule and tablet forms, mints, gums, powders, gels and dissolvable strips.

Probiora3 ® addresses the need for a safe, easily administrable and natural solution for oral care problems. Further, the product is not fettered by dosage constraints and can be included in all possible formats without affecting the efficacy or shelf life of the product.

The company has utilized every available channel to reach out to customers with promotional messages about Probiora3 ®'s exceptional benefits. Oragenics Inc. has partnered with multinational companies that include Probiora3 ® in their formulations, thereby harnessing these companies' substantial marketing power. The company also co-brands and distributes consumer products under its own name in the United States.

"A professional channel that was launched in October 2010 targets the professional oral care community; this outreach effort includes attending trade shows, publishing articles in industry journals, and engaging with universities," notes Dr.Kaushik. "The innovative aspect of this effort is the launch of the continuing education program for oral care professionals, who can access and complete Oragenics, Inc. course work toward credits for their practice license renewal."

Each year, Frost & Sullivan presents this award to the company that has demonstrated superior features and functionality as well as quality and complexity. The company has also exhibited high levels of customization, excellent product mix, and met the requirements of its target market.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.

About Oragenics, Inc.

Oragenics is a leading nutraceutical company focused on oral care probiotics for humans and companion pets. The Company's proprietary products Evora and ProBiora3® are currently sold in over 20 countries. In addition, Oragenics has an exciting pipeline of therapeutic products targeting infectious disease.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.awards.frost.com.

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

BACK TO TOP BACK TO TOP

QUICK SEARCH

GO GO
ADVANCED SEARCH
Search our research by date, market, technology, region or keywords
GO GO
SHARE
ANALYST BRIEFINGS
Attend our complementary interactive analyst briefings
VIEW LIST  VIEW LIST
PRESS RELEASE MAILING LIST
To receive industry breaking news and analysis sign up for our mailing list. Include your full contact details and specify your industry of interest.
URGENT INQUIRIES
We recognize journalist deadlines and will strive to meet your needs as quickly as possible
CONTACT US   CONTACT US
Sitemap | Disclaimer | Privacy
© Frost & Sullivan
Conseq